GRAIL, Inc. Tax Withholding Paid on Stock Awards
GRAIL, Inc. (GRAL) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-03-12
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-09-30 was $0.00.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-12-31 was $14.00K.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-10-01 was -$5.00K.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $0.00.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $234.00K, a 94.41% decline from fiscal 2023.
- GRAIL, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $4.18M.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $9.00K derived: sum of 2 quarters · filed 2026-03-12 | $234.00K 10-K · filed 2025-03-05 | |
| 2023-10-01 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $220.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $225.00K 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | $4.18M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |